Join
Live feed
·
PRReleasevia Quantisnow
Concord Medical Services Holdings Limited logo

Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CCM (Concord Medical Services Holdings Limited) and more on Quantisnow.